Tcw Group Inc Edwards Lifesciences Corp Transaction History

Tcw Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$83.84 - $104.76 $1.17 Million - $1.46 Million	-13,962 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$71.69 - $91.23 $178,866 - $227,618	-2,495 Reduced 15.16%	13,962 $1.27 Million
Q3 2020 Oct 30, 2020	BUY	$67.19 - $87.44 $2,754 - $3,585	41 Added 0.25%	16,457 $1.31 Million
Q2 2020 Aug 05, 2020	BUY	$57.54 - $76.95 $944,576 - $1.26 Million	16,416 New	16,416 $1.14 Million

1,330

457M

2.76M

2.09M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

Stay updated on Tcw Group Inc with notifications on news.